Celltrion
068270.KS
#800
Rank
โ‚น2.074 T
Marketcap
โ‚น10,014
Share price
-0.60%
Change (1 day)
0.04%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚น191.62 Billion

According to Celltrion 's latest financial reports the company's total liabilities are โ‚น191.62 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Celltrion - Total liabilities on balance sheet (from 2007 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚น106.14 B4.51%
2021-12-31โ‚น101.57 B-5.26%
2020-12-31โ‚น107.20 B76.18%
2019-12-31โ‚น60.85 B7.01%
2018-12-31โ‚น56.86 B7.45%
2017-12-31โ‚น52.92 B14.07%
2016-12-31โ‚น46.39 B-12.55%
2015-12-31โ‚น53.05 B-5.92%
2014-12-31โ‚น56.39 B7.97%
2013-12-31โ‚น52.23 B45.05%
2012-12-31โ‚น36.01 B55.44%
2011-12-31โ‚น23.16 B55.16%
2010-12-31โ‚น14.93 B35.42%
2009-12-31โ‚น11.02 B1.93%
2008-12-31โ‚น10.81 B632.2%
2007-12-31โ‚น1.47 B